A method for the quantitative determination of neutral glycosphingolipids in urine sediment
- PMID: 5411982
A method for the quantitative determination of neutral glycosphingolipids in urine sediment
Abstract
A method is described for the isolation and quantitation of six neutral glycosyl ceramides from human urinary sediment. Total lipids were extracted from sediments of 24-hr urine collections, and the glycosyl ceramides were isolated by silicic acid column chromatography followed by thin-layer chromatography. Methanolysis of the individual glycosyl ceramides yielded methyl glycosides which were quantitated as the trimethylsilyl ethers by gas-liquid chromatography. By this technique, the submicromolar concentrations of six glycosyl ceramides in normal subjects and in individuals with Fabry's disease, an hereditary glycosphingolipid storage disease, were determined. Trihexosyl ceramide (galactosyl-galactosylglucosyl ceramide) and a digalactosyl ceramide accumulated in the urinary sediment of patients with Fabry's disease.
Similar articles
-
Urinary glycolipids in Fabry's disease. Their examination in the detection of atypical variants and the pre-symptomatic state.Pediatrics. 1969 Feb;43(2):201-6. Pediatrics. 1969. PMID: 5763858 No abstract available.
-
Quantitative determination of the neutral glycosyl ceramides in human blood.J Lipid Res. 1967 Nov;8(6):621-30. J Lipid Res. 1967. PMID: 6057492
-
Concentrations of glycosyl ceramides in plasma and red cells in Fabry's disease, a glycolipid lipidosis.J Lipid Res. 1969 Mar;10(2):188-92. J Lipid Res. 1969. PMID: 5782355
-
Human urinary sulfatides in patients with sulfatidosis (metachromatic leukodystrophy).J Lipid Res. 1971 Jul;12(4):434-41. J Lipid Res. 1971. PMID: 5164093
-
Recent advances in Fabry's disease.Trans Assoc Am Physicians. 1970;83:121-32. Trans Assoc Am Physicians. 1970. PMID: 4928424 Review. No abstract available.
Cited by
-
I-cell disease (mucolipidosis II):a report on its pathology.Acta Neuropathol. 1975 Dec 30;33(4):285-305. doi: 10.1007/BF00686161. Acta Neuropathol. 1975. PMID: 3084
-
Differential human urinary lipid profiles using various lipid-extraction protocols: MALDI-TOF and LIFT-TOF/TOF analyses.Sci Rep. 2016 Sep 20;6:33756. doi: 10.1038/srep33756. Sci Rep. 2016. PMID: 27646409 Free PMC article.
-
Comparative urinary globotriaosylceramide analysis by thin-layer chromatography-immunostaining and liquid chromatography-tandem mass spectrometry in patients with Fabry disease.Mol Genet Metab Rep. 2021 Sep 28;29:100804. doi: 10.1016/j.ymgmr.2021.100804. eCollection 2021 Dec. Mol Genet Metab Rep. 2021. PMID: 34631425 Free PMC article.
-
Prosaposin deficiency and saposin B deficiency (activator-deficient metachromatic leukodystrophy): report on two patients detected by analysis of urinary sphingolipids and carrying novel PSAP gene mutations.Am J Med Genet A. 2009 Feb 15;149A(4):613-21. doi: 10.1002/ajmg.a.32712. Am J Med Genet A. 2009. PMID: 19267410 Free PMC article.
-
Efficacy of Enzyme and Substrate Reduction Therapy with a Novel Antagonist of Glucosylceramide Synthase for Fabry Disease.Mol Med. 2015 Apr 30;21(1):389-99. doi: 10.2119/molmed.2015.00088. Mol Med. 2015. PMID: 25938659 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
